Thursday, September 25, 2025
StockstToday.com Logo
  • Home
  • Tech & Software
  • Earnings
  • Analysis
  • Trading & Momentum
  • Cryptocurrency
  • Banking & Insurance
  • AI & Quantum Computing
No Result
View All Result
  • Home
  • Tech & Software
  • Earnings
  • Analysis
  • Trading & Momentum
  • Cryptocurrency
  • Banking & Insurance
  • AI & Quantum Computing
No Result
View All Result
StocksToday.com Logo
No Result
View All Result
Home Stocks

Expedia Stock: Soars to Record High on Stellar Earnings

Robert Sasse by Robert Sasse
August 9, 2025
in Stocks
0
Expedia Stock
0
SHARES
0
VIEWS
Share on FacebookShare on Twitter

Expedia’s shares surged 13.5% to a 52-week high of $212.06 on Friday, capping a 59.75% annual gain, fueled by stronger-than-expected Q2 results. The travel giant reported earnings of $4.24 per share, surpassing forecasts of $3.96, while revenue hit $3.79 billion against estimates of $3.7 billion. Key growth drivers included a 17% jump in B2B bookings and a 19% rise in advertising revenue, underscoring its robust international presence. Adjusted EBITDA margins expanded by 190 basis points to 24%, reflecting improved profitability.

Analysts Rally Behind Upgraded Targets

Wall Street responded with bullish price-target hikes, including raises to $218 (DA Davidson) and $240 (BofA). Efficiency gains—from job cuts and AI adoption—slashed overhead costs to 16.8% of revenue. While U.S. consumer demand remained subdued, international leisure bookings grew 13%, and CEO Ariane Gorin noted a recent uptick in American travel sentiment. Expedia raised its full-year booking growth forecast to 3–5%, with margins expected to improve by another 100 basis points. The stock’s pre-market spike to $216 signals sustained investor confidence.

Ad

Expedia Stock: Buy or Sell?! New Expedia Analysis from September 25 delivers the answer:

The latest Expedia figures speak for themselves: Urgent action needed for Expedia investors. Is it worth buying or should you sell? Find out what to do now in the current free analysis from September 25.

Expedia: Buy or sell? Read more here...

Tags: Expedia
Robert Sasse

Robert Sasse

About Dr. Robert Sasse Accomplished economist, entrepreneur, and profound expert in financial markets. Dr. Robert Sasse holds a doctorate in economics and combines academic rigor with practical entrepreneurial experience. His deep expertise in economic relationships and unwavering conviction for a free-market liberal economic order drives his mission to provide investors with well-founded knowledge and guidance.
Areas of Expertise:
  • Economic Theory and Practice
  • Free-Market Economics
  • Entrepreneurship and Business Strategy
  • Investment Philosophy
Dr. Sasse's unique combination of academic knowledge and real-world business experience enables him to provide investors with comprehensive insights that bridge theory and practice.

Related Posts

Quantum Computing Stock
Stocks

Quantum Computing Stock Dips Despite Major Contract Wins

September 16, 2025
Coinbase Stock
Stocks

Institutional Partnership Fuels Optimism for Coinbase’s Future

September 16, 2025
Strategy Stock
Stocks

MicroStrategy’s Bitcoin Bet Faces Market Skepticism

September 16, 2025
Next Post
Münchener Rück Stock

Münchener Rück Stock: Record Profit Masked by Market Jitters

Gilead Sciences Stock

Gilead Sciences Stock: HIV Success Fuels Analyst Optimism

The Trade Desk Stock

The Trade Desk Stock: Plunges 32% on Downgrade, Growth Fears

Recommended

Finance_ Investing in stocks

Robinhood Markets Inc Reports Impressive Growth Metrics and Stock Price Surge

2 years ago
Sprout Social Stock

Leadership Turmoil at Sprout Social Overshadows Operational Progress

6 days ago
Norma Stock

Norma Stock: Defying Expectations Amid Sector Challenges

1 month ago
Hannover Rueck Stock

Hannover Rueck Stock: Record Profits Defy Market Challenges

1 month ago

Categories

  • AI & Quantum Computing
  • Analysis
  • Analyst Ratings
  • Asian Markets
  • Automotive & E-Mobility
  • Banking & Insurance
  • Bitcoin
  • Blockchain
  • Bonds
  • Breaking News
  • Business & Industry Trends
  • Cannabis
  • Chemicals
  • Commodities
  • Consumer & Luxury
  • Crypto Stocks
  • Cryptocurrency
  • Cyber Security
  • DAX
  • Defense & Aerospace
  • Dividends
  • Dow Jones
  • E-Commerce
  • Earnings
  • Emerging Markets
  • Energy & Oil
  • ETF
  • Ethereum & Altcoins
  • European Markets
  • Forex
  • Gaming & Metaverse
  • Gold & Precious Metals
  • Healthcare
  • Hydrogen
  • Index
  • Industrial
  • Insider Trading
  • IPOs
  • Market Commentary
  • Market News
  • MDAX & SDAX
  • Mergers & Acquisitions
  • Nasdaq
  • Penny Stocks
  • Pharma & Biotech
  • Real Estate & REITs
  • Renewable Energy
  • S&P 500
  • Semiconductors
  • Space
  • Stock Picks
  • Stock Targets
  • Stocks
  • TecDAX
  • Tech & Software
  • Telecommunications
  • Trading & Momentum
  • Turnaround
  • Uncategorized
  • Value & Growth

Topics

AAPL Adobe Alibaba Alphabet Amazon AMD Apple ASML BA BigBear.ai BioNTech Broadcom Coinbase Eli Lilly Fiserv Hims & Hers IBM Intel Kraft Heinz Lockheed Marvell Technology META Micron Microsoft MP Materials MSCI World ETF NIO Nvidia Opendoor Oracle Oxford Lane Capital Palantir PayPal Pepsi Red Cat Robinhood Rocket Lab USA Salesforce Strategy Super Micro Computer Tesla TSLA Unitedhealth Viking Therapeutics Wolfspeed
No Result
View All Result

Highlights

Almonty Industries Launches Major Exploration Initiative for Critical Mineral

Nel ASA Shares Experience Sharp Reversal After Recent Highs

BASF’s Strategic Overhaul: A Calculated Transformation

Hensoldt Shares Surge Past €100 Milestone on Technical and Sector Momentum

Bitcoin Navigates Critical Juncture Following Multi-Billion Dollar Sell-Off

Parkinson Therapy Breakthrough Fails to Lift Bayer’s Stock

Trending

Redcare Pharmacy Stock
Analysis

Redcare Pharmacy: Diverging Signals Create Critical Juncture for Investors

by Dieter Jaworski
September 25, 2025
0

Redcare Pharmacy finds itself at a critical crossroads, presenting investors with a complex puzzle. The online pharmacy's...

Eutelsat Stock

Eutelsat Forges Strategic Path with Skynopy Ground Station Agreement

September 25, 2025
Cardano Stock

Cardano at a Critical Juncture: Can a $50 Million Boost Reverse the Trend?

September 25, 2025
Almonty Stock

Almonty Industries Launches Major Exploration Initiative for Critical Mineral

September 25, 2025
Nel ASA Stock

Nel ASA Shares Experience Sharp Reversal After Recent Highs

September 25, 2025

StocksToday.com is your one-stop destination for the latest stock news and analysis. We provide in-depth coverage of the stock market, including market news, company news, sector news, IPO news, investment strategies, personal finance, international markets, and more.

Follow us on social media:

Recent News

  • Redcare Pharmacy: Diverging Signals Create Critical Juncture for Investors
  • Eutelsat Forges Strategic Path with Skynopy Ground Station Agreement
  • Cardano at a Critical Juncture: Can a $50 Million Boost Reverse the Trend?

Category

  • About
  • Advertise
  • Careers
  • Contact
  • Imprint
  • Privacy Policy
  • Terms of Service

© 2023 StocksToday.com

No Result
View All Result
  • Home
  • Tech & Software
  • Earnings
  • Analysis
  • Trading & Momentum
  • Cryptocurrency
  • Banking & Insurance
  • AI & Quantum Computing

© 2023 StocksToday.com